Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Agents and Actions. Supplements
|
January 1, 1988
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs
C P Page, D N Robertson, A J Coyle
Contraception
|
October 1, 1978
Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels
H A Nash, D N Robertson, T M Jackanicz
Contraception
|
June 1, 1979
A three-year clinical trial with levonorgestrel silastic implants
S Diaz, M Pavez, D N Robertson, et al.
Contraception
|
March 1, 1983
Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD
H B Croxatto, S Diaz, D N Robertson, et al.
Acta Endocrinologica
|
March 1, 1980
Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices
C G Nilsson, P Lähteenmäki, D N Robertson, et al.
British Journal of Pharmacology
|
July 1, 1989
The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin
E J Dixon, P Wilsoncroft, D N Robertson, et al.
Fertility and Sterility
|
June 1, 1986
Sustained intrauterine release of levonorgestrel over five years
C G Nilsson, P L Lahteenmaki, T Luukkainen, et al.
Contraception
|
August 1, 1977
Clinical trial with subdermal implants of the progestin R-2323
S Diaz, M Pavez, E Quniteros, et al.
Studies in Family Planning
|
June 1, 1983
A four-year clinical study of NORPLANT implants
I Sivin, S Diaz, P Holma, et al.
Contraception
|
May 1, 1983
Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans
D N Robertson, I Sivin, H A Nash, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Agents and Actions. Supplements
|
January 1, 1988
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs
C P Page, D N Robertson, A J Coyle
Contraception
|
October 1, 1978
Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels
H A Nash, D N Robertson, T M Jackanicz
Contraception
|
June 1, 1979
A three-year clinical trial with levonorgestrel silastic implants
S Diaz, M Pavez, D N Robertson, et al.
Contraception
|
March 1, 1983
Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD
H B Croxatto, S Diaz, D N Robertson, et al.
Acta Endocrinologica
|
March 1, 1980
Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices
C G Nilsson, P Lähteenmäki, D N Robertson, et al.
British Journal of Pharmacology
|
July 1, 1989
The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin
E J Dixon, P Wilsoncroft, D N Robertson, et al.
Fertility and Sterility
|
June 1, 1986
Sustained intrauterine release of levonorgestrel over five years
C G Nilsson, P L Lahteenmaki, T Luukkainen, et al.
Contraception
|
August 1, 1977
Clinical trial with subdermal implants of the progestin R-2323
S Diaz, M Pavez, E Quniteros, et al.
Studies in Family Planning
|
June 1, 1983
A four-year clinical study of NORPLANT implants
I Sivin, S Diaz, P Holma, et al.
Contraception
|
May 1, 1983
Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans
D N Robertson, I Sivin, H A Nash, et al.
Page
of 4